"When you’re looking for a highly-qualified Neurologist who puts the needs of the patient first, look to The Neurological Institute. As the most dynamic Neurology group practice in the Piedmont area of the Carolinas, we provide the health services you need in a compassionate and timely manner."

During the past decade, The Neurological Institute, PA conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Neurological Institute, PA" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Epix Pharmaceuticals, Inc." with 2 trials sponsored, "Newron Pharmaceuticals SPA" with 2 trials sponsored and "Acorda Therapeutics" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Neurological Institute, PA" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "Sunovion" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "The Neurological Institute, PA" are "Multiple Sclerosis" (5 trials), "Relapsing Multiple Sclerosis" (3 trials), "Alzheimer's Disease" (2 trials), "Idiopathic Parkinson's Disease" (2 trials) and "Partial Epilepsy" (2 trials). Many other conditions were trialed in "The Neurological Institute, PA" in a lesser frequency.

Most popular intervention types in "The Neurological Institute, PA" are "Drug" (20 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Ocrelizumab" (3 trials), "Interferon beta-1a" (2 trials), "Ozanimod" (2 trials) and "PRX-03140" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Neurological Institute, PA" are 21 trials for "All" genders.

Currently, there are NaN active trials in "The Neurological Institute, PA". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in The Neurological Institute, PA, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The Neurological Institute, PA, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".